注冊以創建關於儀器的通知
你所追隨的作者的經濟活動和內容
免費註冊 已有帳戶? 登入
Catalent Inc是一家為藥物、細胞和基因療法生物製劑、疫苗和消費者保健產品提供開發和製造解決方案的供應商。該公司的部門包括生物製劑、軟膠囊和口服技術、口服和專業遞送以及臨床供應服務。其生物製品部門為蛋白質、質粒DNA mRNA、細胞療法、病毒疫苗和基於病毒的基因療法提供開發和製造。其軟膠囊和口服技術部門提供軟膠囊的配方、開發和製造服務,以及口服固體劑型的大規模製造。其口服和特殊給藥部門提供一系列技術的配方開發和製造,以及集成的下游臨床開發和商業供應解決方案。其臨床供應服務部門為藥物、生物製品和臨床試驗提供製造、包裝、儲存、分銷和庫存管理。
名稱 | 年齡 | 成立於 | 主旨 |
---|---|---|---|
Rolf A. Classon | 78 | 2014 | Independent Director |
Jack L. Stahl | 70 | 2014 | Independent Lead Director |
Gregory T. Lucier | 59 | 2015 | Independent Director |
Alessandro Maselli | 51 | 2016 | President, CEO & Director |
John J. Greisch | 68 | 2018 | Executive Chairman of the Board |
Edward R. Robinson | - | 2015 | Member of Advisory Board |
Donald Eugene Morel | 65 | 2015 | Independent Director |
Michael J. Buckley | 62 | 2015 | Member of Advisory Board |
Carolyn R. Bertozzi | 56 | 2015 | Member of Scientfic & Advisory Board |
Barry C. Buckland | 75 | 2015 | Member of Advisory Board |
Daniel R. Marshak | 66 | 2015 | Member of Advisory Board |
J. Martin Carroll | 74 | 2015 | Independent Director |
Matthew R. Stober | 56 | - | Member of the Biologics Advisory Board |
Steven K. Barg | 60 | 2023 | Independent Director |
David E. Schaffer | 54 | 2019 | Member of the Biologics Advisory Board |
Stephanie Smith Okey | 63 | 2023 | Independent Director |
Michael J. Barber | 63 | 2021 | Independent Director |
Michelle R. Ryan | 57 | 2023 | Independent Director |
Frank A. D'Amelio | 66 | 2023 | Independent Director |
你確定要封鎖 %USER_NAME%?
此舉將會令你與 %USER_NAME% 之間無法看見對方的Investing.com貼文。
%USER_NAME% 已成功加入你的封鎖清單
你剛解除此人的封鎖,必須等候 48 小時後才可再次封鎖。
我覺得這個評論是:
謝謝!
您的報告已被發送到我們的版主審核